Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas

Leukemia. 2007 Dec;21(12):2554-6. doi: 10.1038/sj.leu.2404819. Epub 2007 Jun 21.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Disease-Free Survival
  • Drug Resistance, Neoplasm
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphocyte Count*
  • Lymphoma, Follicular / blood
  • Lymphoma, Follicular / mortality
  • Lymphoma, Follicular / radiotherapy*
  • Male
  • Middle Aged
  • Prognosis
  • Radioimmunotherapy*
  • Recurrence
  • Rituximab
  • Salvage Therapy*
  • Survival Analysis
  • Yttrium Radioisotopes / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Yttrium Radioisotopes
  • Rituximab
  • ibritumomab tiuxetan